AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Metstair 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Elisa Biotech Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Metstair 1mg/500mg Tablet SR

Diabexe Duo 1mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabexe Duo should be administered with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Diabexe Duo is part of a comprehensive diabetes management plan, encompassing a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle modifications significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most frequent adverse effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks or juice) are essential to mitigate this risk. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional side effects may include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is a possibility. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating women require medical consultation before use. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.

Uses of Metstair 1mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Metstair 1mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Metstair 1mg/500mg Tablet SR whole; avoid crushing, chewing, or breaking it. Administer this extended-release tablet with a meal.

Common Side effects of Metstair 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Metstair 1mg/500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Metstair 1mg/500mg Extended-Release Tablet with food.

How Metstair 1mg/500mg Tablet SR works:

Metformin/Glimepiride 500mg/1mg extended-release tablets combine two antidiabetic agents to manage blood sugar. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol consumption and Metstair 1mg/500mg SR tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Metstair 1mg/500mg sustained-release tablets during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Metstair tablets (1mg/500mg) are contraindicated for breastfeeding mothers due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Metstair 1mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Medical consultation is essential. Metstair 1mg/500mg Tablet SR is contraindicated in individuals with severe kidney disease. Routine kidney function assessments are recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Metstair 1mg/500mg SR tablets cautiously, as dose modification may be necessary. Consult your physician for guidance. For those with mild to moderate liver disease, Metstair 1mg/500mg SR tablets are typically initiated at a low dosage; however, their use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Metstair 1mg/500mg Tablet SR :

Should you forget a Metstair 1mg/500mg SR tablet, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Metstair 1mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Metstair 1mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Metstair 1mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but dangerous side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Metstair 1mg/500mg Tablet SR and seek immediate medical attention.
Metstair 1mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Metstair is not suitable for type 1 diabetes.
Metstair 1mg/500mg Tablet SR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Metstair 1mg/500mg SR tablets can lead to Vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). Annual supplemental Vitamin B12 intake is recommended by some researchers to mitigate these risks.
Metstair 1mg/500mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concomitant use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Metstair 1mg/500mg SR tablets with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Metstair 1mg/500mg Tablet...
84
MRP 98
13% off